Clinical Trial Update: Differential Risks for Melanoma: p16 and DNA Repair

View source ↗

Summary

A completed clinical trial update discusses differential melanoma risk related to p16 status and DNA repair mechanisms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Melanoma, Skin Melanoma | Status: COMPLETED